Abstract：Objective To study the efficacy and safety of vitamin D as an adjuvant therapy for childhood pneumonia through a systematic review. Methods Cochrane Library, PubMed, EMbase, CNKI, Wanfang Data, and Weipu Data were searched for randomized controlled trials (RCTs) of vitamin D as the adjuvant therapy for childhood pneumonia published up to August 2019. Literature screening, quality assessment, and data extraction were performed based on inclusion and exclusion criteria. Revman 5.3 was used to perform the Meta analysis of outcome indicators. Results A total of 7 RCTs with 1 527 children were included, with 762 children in the vitamin D adjuvant therapy group and 765 children in the control group. The results of the Meta analysis showed that vitamin D adjuvant therapy had no effect on recovery time (P=0.67), length of hospital stay (P=0.73), and time to relief of fever (P=0.43). Furthermore, it did not reduce the recurrence rate (P=0.14), rate of adverse events (P=0.20), and mortality rate (P=0.98) of childhood pneumonia. Conclusions Current evidence shows that vitamin D adjuvant therapy has no marked efficacy in the treatment of childhood pneumonia.
MU Shi-Yin,ZOU Ying-Xue,ZHAI Jia et al. Efficacy and safety of vitamin D as adjuvant therapy for childhood pneumonia: a Meta analysis[J]. CJCP, 2020, 22(2): 124-129.
Holland SM, Qader G, Masher MI, et al. Effects of vitamin D supplementation to children diagnosed with neumonia in Kabul:a randomised controlled trial[J]. Trop Med Int Health, 2010, 15:1148-1155.
[4]
Charan J, Goyal JP, Saxena D, et al. Vitamin D for prevention of respiratory tract infections:a systematic review and meta-analysis[J]. J Pharmacol Pharmacother, 2012, 3(4):300-303.
[5]
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials:is blinding necessary[J]. Control Clin Trials, 1996, 17(1):1-12.
[6]
Manaseki-Holland S, Qader G, Isag Masher M, et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul:a randomised controlled trial[J]. Trop Med Int Health, 2010, 15(10):1148-1155.
[7]
Choudhary N, Gupta P. Vitamin D supplementation for severe pneumonia-a randomized controlled trial[J]. Indian Pediatr, 2012, 49(6):449-454.
[8]
Gupta P, Dewan P, Shah D, et al. Vitamin D supplementation for treatment and prevention of pneumonia in under-five children:a randomized double-blind placebo controlled trial[J]. Indian Pediatr, 2016, 53(11):967-976.
[9]
Rahmati MB, Rezapour M, Shahvari SZ. The effects of vitamin D supplementation in respiratory index of severity in children (RISC)of hospitalized patients with community-acquired pneumonia:a double-blind randomized clinical trial[J]. Acta HealthMedica, 2016, 1(3):60-64.
[10]
Rajshekhar CS, Vanaki* R, Badakali AV, et al. Efficacy of vitamin D supplementation in the treatment of severe pneumonia in children aged less than five years[J]. Int J Contemp Pediatr, 2016, 3(1):96-99.
[11]
Somnath SH, Biswal N, Chandrasekaran V, et al. Therapeutic effect of vitamin D in acute lower respiratory infection:a randomized controlled trial[J]. Clin Nutr ESPEN, 2017, 20:24-28.
[12]
Shamaoon M, Maryam, Ahsan M, et al. Vitamin D and pneumonia; Role of vitamin D supplementation in children with pneumonia, a randomised control trial[J]. Professional Med J, 2018, 25(4):532-537.
[13]
Das RR, Singh M, Panigrahi I, et al. Vitamin D supplementation for the treatment of acute childhood pneumonia:a systematic review[J]. ISRN Pediatr, 2013, 2013:459160.
